BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28383372)

  • 1. Maternal, Fetal, and Neonatal Imatinib Levels With Treatment of Chronic Myeloid Leukemia in Pregnancy.
    Burwick RM; Kuo K; Brewer D; Druker BJ
    Obstet Gynecol; 2017 May; 129(5):831-834. PubMed ID: 28383372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breastfeeding in a patient with chronic myeloid leukemia during tyrosine kinase inhibitor therapy.
    Terao R; Nii M; Asai H; Nohara F; Okamoto T; Nagaya K; Azuma H
    J Oncol Pharm Pract; 2021 Apr; 27(3):756-760. PubMed ID: 32787559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib.
    Stella S; Tirró E; Massimino M; Vitale SR; Russo S; Pennisi MS; Puma A; Romano C; DI Gregorio S; Innao V; Stagno F; DI Raimondo F; Musolino C; Manzella L
    In Vivo; 2019; 33(5):1593-1598. PubMed ID: 31471409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukaemia in pregnancy: call for guidelines.
    P P; Samal R; Ghose S
    J Obstet Gynaecol; 2019 May; 39(4):582-583. PubMed ID: 30744447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
    Wang DP; Liang MY; Zhang XH; Wang SM
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib.
    Tsuzuki M; Inaguma Y; Handa K; Hasegawa A; Yamamoto Y; Watanabe M; Mizuta S; Maruyama F; Okamoto M; Emi N
    Intern Med; 2009; 48(16):1433-5. PubMed ID: 19687593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.
    Skoumalova I; Vondrakova J; Rohon P; Rozmanova S; Jarosova M; Indrak K; Prochazka M; Santava A; Faber E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):121-3. PubMed ID: 18795086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful maintenance of molecular remission in chronic myelogenous leukaemia during pregnancy with transition from imatinib to pegylated interferon.
    Ellis M; Mills AK
    Intern Med J; 2015 Mar; 45(3):358-9. PubMed ID: 25735582
    [No Abstract]   [Full Text] [Related]  

  • 9. Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk.
    Russell MA; Carpenter MW; Akhtar MS; Lagattuta TF; Egorin MJ
    J Perinatol; 2007 Apr; 27(4):241-3. PubMed ID: 17377606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib use during pregnancy and breast feeding: a case report and review of the literature.
    Ali R; Ozkalemkas F; Kimya Y; Koksal N; Ozkocaman V; Gulten T; Yorulmaz H; Tunali A
    Arch Gynecol Obstet; 2009 Aug; 280(2):169-75. PubMed ID: 19083009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes.
    Stagno F; Stella S; Spitaleri A; Pennisi MS; Di Raimondo F; Vigneri P
    Expert Rev Anticancer Ther; 2016; 16(3):273-8. PubMed ID: 26852913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery.
    Yadav U; Solanki SL; Yadav R
    J Cancer Res Ther; 2013; 9(3):484-6. PubMed ID: 24125987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy.
    Mainor CB; Duffy AP; Atkins KL; Kimball AS; Baer MR
    J Oncol Pharm Pract; 2016 Apr; 22(2):374-7. PubMed ID: 25616656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy: part of life in chronic myelogenous leukemia.
    Law AD; Dong Hwan Kim D; Lipton JH
    Leuk Lymphoma; 2017 Feb; 58(2):280-287. PubMed ID: 27389567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
    Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
    Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
    Buyukbayrak EE; Ergen B; Karsidag YK; Kars B; Turan C; Argon D
    Arch Gynecol Obstet; 2008 Aug; 278(2):161-3. PubMed ID: 18193246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib.
    Heartin E; Walkinshaw S; Clark RE
    Leuk Lymphoma; 2004 Jun; 45(6):1307-8. PubMed ID: 15360020
    [No Abstract]   [Full Text] [Related]  

  • 18. Generic imatinib in the treatment of chronic myeloid leukemia: two years' experience in Latvia.
    Lejniece S; Udre I; Rivkina A
    Exp Oncol; 2017 Jul; 39(2):151-154. PubMed ID: 29483494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spotlight on imatinib mesylate in chronic myeloid leukemia.
    Curran MP; Croom KF; Goa KL
    BioDrugs; 2004; 18(3):207-10. PubMed ID: 15161340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
    Mesquita MM; Pestana A; Mota A
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.